Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Rhea-AI Summary

Sangamo Therapeutics (NASDAQ: SGMO) has announced its participation in upcoming investor conferences. The 2021 Virtual Wells Fargo Healthcare Conference is scheduled for September 10 at 3:20 p.m. ET. Next, at the H.C. Wainwright & Co. 23rd Annual Global Investment Conference, Sangamo will present on September 13 at 7:00 a.m. ET. Lastly, the Morgan Stanley 19th Annual Global Healthcare Conference will take place on September 15 at 10:15 a.m. ET. Presentations will be available for webcasting and later on Sangamo's website under Events and Presentations.

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in fireside chats at the following investor conferences:

• 2021 Virtual Wells Fargo Healthcare Conference
  Date: Friday, September 10^th at 3:20 p.m. Eastern Time

• H.C. Wainwright & Co. 23^rd Annual Global Investment Conference
  Date: Monday, September 13^th at 7:00 a.m. Eastern Time

• Morgan Stanley 19^th Annual Global Healthcare Conference
  Date: Wednesday, September 15^th at 10:15 a.m. Eastern Time

For presentations that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don’t exist. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210831005047/en/

Investor Relations & Media Inquiries

Aron Feingold

628.252.7494

afeingold@sangamo.com

Source: Sangamo Therapeutics, Inc.

FAQ

What investor conferences is Sangamo Therapeutics participating in?

Sangamo Therapeutics is participating in the Wells Fargo Healthcare Conference on September 10, H.C. Wainwright & Co. Conference on September 13, and Morgan Stanley Healthcare Conference on September 15, 2021.

When is the Wells Fargo Healthcare Conference?

The Wells Fargo Healthcare Conference is on September 10, 2021, at 3:20 p.m. Eastern Time.

What time is the H.C. Wainwright & Co. Conference for Sangamo?

Sangamo's presentation at the H.C. Wainwright & Co. Conference is scheduled for September 13, 2021, at 7:00 a.m. Eastern Time.

When will Sangamo present at the Morgan Stanley Healthcare Conference?

Sangamo will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 15, 2021, at 10:15 a.m. Eastern Time.

Where can I access Sangamo's conference presentations?

Sangamo's conference presentations will be available for webcasting on their website and can be accessed in the Investors and Media section.